Literature DB >> 6139567

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

E N Harris, A E Gharavi, M L Boey, B M Patel, C G Mackworth-Young, S Loizou, G R Hughes.   

Abstract

A new solid-phase radioimmunoassay for the detection of anticardiolipin antibodies is 200-400 times more sensitive than the precipitation method used in the Venereal Disease Reference Laboratory test. 61% of serum samples from patients with systemic lupus erythematosus (SLE) had high levels of anticardiolipin antibodies of at least one immunoglobulin class. There were strong correlations between raised anticardiolipin levels and the lupus anticoagulant, venous and arterial thrombosis, and thrombocytopenia, but no correlation with anti-DNA antibody levels. Of the 15 patients with the highest anticardiolipin titres, 6 had a history of venous thrombosis, 5 cerebral thrombosis, 5 thrombocytopenia, and 2 each pulmonary hypertension and multiple abortions. This simple immunoassay appears to have predictive value for thrombosis in SLE and related disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139567     DOI: 10.1016/s0140-6736(83)91267-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  235 in total

1.  Cardiolipin is a normal component of human plasma lipoproteins.

Authors:  H Deguchi; J A Fernandez; T M Hackeng; C L Banka; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 2.  Testing for and clinical significance of anticardiolipin antibodies.

Authors:  S W Reddel; S A Krilis
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 3.  Recognition and management of systemic lupus erythematosus.

Authors:  J O Schroeder; H H Euler
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

4.  Seronegative antiphospholipid syndrome.

Authors:  G R V Hughes; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

Review 5.  Renal manifestations of the antiphospholipid syndrome.

Authors:  David D'Cruz
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

Review 6.  Neonatal effects of maternal antiphospholipid syndrome.

Authors:  Angela Tincani; Chiara Biasini Rebaioli; Laura Andreoli; Andrea Lojacono; Mario Motta
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

7.  Anti-Klebsiella K30 phospholipid antibodies in systemic lupus erythematosus: antigen cross-reactions and idiotypic sharing with antibodies to DNA and Klebsiella K30 polysaccharide.

Authors:  G D Harkiss; F M Hendrie; D Thompson
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

8.  Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids.

Authors:  M Sutjita; A Hohmann; R Comacchio; J Bradley
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

9.  The anti-phospholipid antibody syndrome in a 77 year old man with digital gangrene.

Authors:  S W Roche; D C Niriella; A O'Mahoney; A C Cayley
Journal:  Postgrad Med J       Date:  1989-11       Impact factor: 2.401

10.  Risk factors for thrombosis in lupus patients.

Authors:  P Hasselaar; R H Derksen; L Blokzijl; M Hessing; H K Nieuwenhuis; B N Bouma; P G De Groot
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.